[1]
Fahim, K. et al. 2026. Omalizumab usage off-label - review of the knowledge obtained over the last 10 years from research in specific diseases. Quality in Sport. 53, (Apr. 2026), 70169. DOI:https://doi.org/10.12775/QS.2026.53.70169.